Musso Alan A 4
4 · Fulcrum Therapeutics, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Musso Alan A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-24+285,000→ 285,000 totalExercise: $4.16Exp: 2035-01-23→ Common Stock (285,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 24, 2025 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2025, subject to the reporting person's continued service on each such vesting date.